Clinical Trials · NCT06706284
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Marzieh Salehi
- Enrollment
- 50
- Start date
- Apr 2025
- Locations
- 2 sites, United States
- Primary endpoint
- Glucose tolerance